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Does Information on Blood Heavy Metals Improve Cardiovascular
Mortality Prediction?
Xin Wang, MPH; Bhramar Mukherjee, PhD; Sung Kyun Park, ScD
Background-—To evaluate whether blood markers of lead, cadmium, and mercury can improve prediction for cardiovascular
disease (CVD) mortality when added individually, jointly, or as an integrative index/Environmental Risk Score (ERS), in a model with
established risk factors.
Methods and Results-—Our study sample comprised 16 028 adults aged ≥40 years who were enrolled in the National Health and
Nutrition Examination Survey 1999–2012 and followed up through December 31, 2015. The study sample was randomly split into
training for the ERS construction (n=8043) and testing for the evaluation of prediction performance (n=7985). ERS was computed
using elastic-net penalized Cox’s model based on the selected metal predictors predicting CVD mortality. During median follow-up
of 7.2 years, 517 died from CVD. In the training set, linear terms of cadmium and mercury, squared terms of lead and mercury, and
all 3 pairwise interactions were selected by elastic-net for ERS construction. In the testing set, the C-statistic increased from 0.845
when only established CVD risk factors were in the model to 0.854 when the ERS was additionally added to the model. Addition of
all linear, squared, and pairwise interaction terms of blood metals to the Cox’s models improved C-statistic from 0.845 to 0.857.
The improvement remained significant when it was assessed by net reclassification improvement and integrated discrimination
improvement.
Conclusions-—Our findings suggest that blood markers of toxic metals can improve CVD risk prediction over the established risk
factors and highlight their potential utility for CVD risk assessment, prevention, and precision health. ( J Am Heart Assoc. 2019;8:
e013571. DOI: 10.1161/JAHA.119.013571.)
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C ardiovascular disease (CVD) remains the leading causeof death in the United States as well as globally.1,2
Accurate assessment of CVD risk as an essential step toward
disease prevention is an important public health goal. Scoring
algorithms such as the Framingham Risk Score and the
Pooled Cohort Equations (PCE) for the atherosclerotic CVD
risk,3,4 which combines the established risk factors, for
example, systolic blood pressure, serum lipid levels, smoking,
obesity, and diabetes mellitus, have been widely used for
cardiovascular risk assessment in the general population.
However, the accuracy of such algorithms has been ques-
tioned.5 Attempts to improve risk prediction algorithms have
been made by incorporating additional risk factors, including
novel biomarkers, subclinical measures, and genetic varia-
tions.6–15 However, the incremental information with regard
to the prediction of cardiovascular events and death added by
those risk markers beyond that of the established risk factors
were mostly small or inconclusive.6–8,16–19
Exposure to environmental toxicants, such as lead,
cadmium, and mercury, are known to have lasting adverse
effects on the cardiovascular system, for example, hyperten-
sion, coronary heart disease, peripheral arterial disease,
stroke, as well as mortality.20–26 Although associations
between blood lead, cadmium, and mercury and risk of
CVD-related morbidity and mortality have been extensively
reported,20,25,27 the predictive value of blood measures of
these toxic metals has never been examined.
The present study attempted to evaluate whether blood
markers of toxic metals (lead, cadmium, and mercury) can
improve prediction for CVD mortality when added individually,
jointly, or as an integrative index—the Environmental Risk
Score (ERS), in a model with established CVD risk factors. The
ERS has been suggested as a summary measure of health risk
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of exposure to multiple toxicants in epidemiological
research.28,29 Data from the National Health and Nutrition
Examination Survey (NHANES), that represents the general
US population, were used to develop and validate our model.
Methods
Study Population
The study sample consists of 7 continuous cycles of theNHANES
between 1999 and 2012, which used a stratified, multistage
probability cluster design, with oversampling of selected
subpopulations, to obtain a representative sample of the civilian,
noninstitutionalized US population.30 All data andmaterials have
been made publicly available at the National Center for Health
Statistics website (https://www.cdc.gov/nchs/nhanes/index.
htm). The protocols for NHANES were approved by the National
Center for Health Statistics of the Centers for Disease Control
and Prevention Institutional Review Board, and informed
consents were obtained from all participants.
Blood metal concentrations were measured in the entire
NHANES samples through all cycles between 1999 and 2012
except for total blood mercury, which was available among
participants aged 1 to 5 years and females aged 16 to
49 years in 2 earlier cycles (1999–2000 and 2001–2002).30
Because individuals aged <40 years have very low cardiovas-
cular risk,4,31 we restricted our analysis using individuals aged
≥40 years. Among a total of 17 284 men and women aged
≥40 years who completed blood sample collections for lead,
cadmium, and total mercury assessments in NHANES 1999–
2012, 17 260 participants were linked with the mortality data
available in the National Death Index. We excluded partici-
pants with missing information on systolic blood pressure
(n=752), current smoking status (n=14), total cholesterol and
high-density lipoprotein (HDL) cholesterol levels (n=258), and
body mass index (n=322; the numbers are not mutually
exclusive), leaving a total of 16 028 participants for the
current study. We randomly split our study by a ratio of 1:1
into the training set (n=8043) for construction of the CVD
death-related ERS of blood metals, and the testing set
(n=7985) for evaluation of performances of blood metals,
including the constructed ERS, for predicting CVD mortality in
addition to the established risk factors. An overview of our
methodology is depicted in Figure S1.
Blood Metal Measurements
Blood lead, cadmium, and total mercury were measured at the
Environmental Health Sciences Laboratory of the Centers for
Disease Control and Prevention National Center for Environ-
mental Health following extensive quality-control proce-
dures.30 The limit of detection (LOD) for blood lead was
0.3 lg/dL (system of units conversion, multiply by 0.0483 for
lmol/L) in NHANES 1999–2004 and 0.25 lg/dL in 2005–
2012.30 For blood cadmium, the LOD was 0.3 lg/L (system
of units conversion, multiply by 8.897 for nmol/L) in 1999–
2002 and 0.2 lg/L in 2003–2012.30 LODs for total blood
mercury varied according to cycle and batch, ranging between
0.14 and 0.33 lg/L (system of units, multiply by 4.99 for
nmol/L).30 Of all participants in our analysis, 0.1%, 11.8%, and
8.6% had blood lead, cadmium, and mercury concentrations
below LODs, respectively. Metal concentrations below LODs
were assigned with the LOD divided by the square root of 2.
Outcomes
The public use NHANES linked mortality data, which linked
NHANES records with death certificates from the National
Death Index using probabilistic matching algorithms, was
used to determine the vital status and cause of death. A
detailed description of the matching criteria and calibration is
available from the National Center for Health Statistics.32 All
participants were followed up through December 31, 2015.
The International Classification of Diseases, Tenth Revision
(ICD-10) was used to determine the underlying cause of
death. Death from cardiovascular causes (ICD-10 codes I00–
I09, I11, I13, I20–I51, and I60–I69) were identified.
Other Covariates
Information on age, sex, race/ethnicity (Hispanic including
Mexican American and other Hispanic, non-Hispanic white,
Clinical Perspective
What Is New?
• For the first time, the predictive value of blood markers of
toxic metals, including lead, cadmium, and mercury, for
cardiovascular disease mortality was assessed in a repre-
sentative sample of US adults aged ≥40 years.
• Addition of multiple predictors of blood lead, cadmium, and
mercury to the established risk factors significantly
improved risk discrimination and risk reclassification of
cardiovascular disease mortality.
What Are the Clinical Implications?
• Assessment of blood toxic metals may be useful for
identifying subpopulations that may benefit most from
additional blood tests for predicting cardiovascular disease
mortality.
• Our findings highlight a potential utility of assessment of
exposure to environmental toxicants for cardiovascular
disease risk assessment and prevention.
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non-Hispanic black, and other), and current smoking status was
collected using self-administered questionnaires.30 Blood
pressures were measured 3 consecutive times (sometimes 4
times) with each participant in a seated position by using a
standardized protocol following the American Heart Associa-
tion guidelines.33 We calculated means of systolic blood
pressure (mm Hg) by averaging up to 3 measures after
disregarding the first reading. Serum total cholesterol (mg/
dL) was measured using enzymatic methods.30 Serum HDL
cholesterol (mg/dL) was measured by heparin-manganese
precipitation methods.30 Body mass index was calculated as
weight in kilograms divided by the square of height in meters.
Diabetes mellitus was defined as self-reported physician
diagnosis of diabetes mellitus, use of self-reported antidiabetes
medication, or hemoglobin A1c level ≥6.5%. Serum CRP (C-
reactive protein) was analyzed by high-sensitivity latex-
enhanced nephelometry.30 Family history of CVD was deter-
mined based on response (yes or no) to the following NHANES
question: “Including living and deceased, were any of your close
biological that is, blood relatives including father, mother,
sisters or brothers, ever told by health professional that they
had a heart attack or angina before the age of 50?”30
Statistical Analysis
Logarithmic transformations with natural base were applied to
blood lead, cadmium, and mercury concentrations given the
highly skewed distributions of metals. Cox’s proportional
hazards models were performed to examine the associations
between blood metals and CVD mortality. We report effect
estimates (hazards ratios and 95% CIs) comparing the 75th
versus the 25th percentile of blood metal concentrations. All
the models were adjusted for the following predictors used in
the PCE, including age, sex, race/ethnicity, current smoking
status, use of antihypertensive medications, total cholesterol
level, HDL cholesterol level, diabetes mellitus, and body mass
index.
Performance of blood metals for predicting CVD mortality
was assessed progressively. Initially, the linear term of each
log-transformed metal concentration was individually evalu-
ated in the model for CVD mortality with adjustment for the
established risk factors (predictors used in the PCE). We then
examined whether the addition of a “full combination” of
blood metals improved the predictive performance by incor-
porating all 3 linear terms, 3 squared terms, and 3 pairwise
interactions of blood lead, cadmium, and mercury, a total of 9
predictors, simultaneously in the model adjusting for the
established risk factors. The squared terms accounted for
nonlinear associations between metals and CVD mortality,
and interaction terms implied potential departures from
additive effects. Finally, we created a parsimonious, rather
than comprehensive, index—the ERS, for integrating CVD
death risk of exposure to metals only based on the most
important metal predictors necessary to predict CVD death.
The underlying idea behind the ERS is to build a predictive risk
score as a weighted sum of the toxicant concentrations from
simultaneous assessment of multiple toxicants.34 Weights are
determined by the magnitudes of the associations of each
toxicant, as well as toxicant-toxicant interactions, with the
outcome of interest from the regression model.28,29 To
achieve this goal, first we utilized the elastic net (ENET)
penalized Cox’s regression,35 as a machine learning algorithm
designed for variable selection, to identify a parsimonious set
of blood metal predictors associated with CVD mortality in the
training set. Cox’s proportional hazards model is the most
popular survival model for studying the relationship between
survival time and predictor variables. However, this conven-
tional method does not work well in the presence of
potentially high-dimensional predictors or when predictors
are highly correlated (multicollinearity).36 To combat these
issues, the ENET penalized model, as one of the sparse
penalized Cox’s model, has been introduced, which was
proved satisfactory in both handling correlated covariates and
prediction performance.35 ENET shrinks coefficients of “unim-
portant” predictors toward exact zeroes and thus promises to
be a useful tool for variable selection.35,37 In our analysis, 3
linear terms, 3 squared terms, and 3 pairwise interactions of
blood lead, cadmium, and mercury, which were all included in
the model in our initial step, served as predictors to be
selected in the ENET. Age, sex, smoking, and race/ethnicity
were always adjusted for (“forced”) in the model selection as
confounders. Other established CVD risk factors, including
systolic blood pressure, use of antihypertensive medications,
total cholesterol, HDL cholesterol, diabetes mellitus, and body
mass index, were not forced because of their potential role of
intermediates on the pathways between blood metals and
CVD death.29,38,39 The ENET penalized parameters were
ascertained based on a 5-fold cross-validation for minimal
prediction errors. We also repeated this procedure based on
10-fold cross-validation, and the results were consistent. The
R package “fastcox” was used to implement ENET penalized
Cox’s model.35 We also used another R package that supports
ENET Cox regression models, “coxnet,” and obtained consis-
tent results.40 The ERS was then computed in the testing set
as a weighted sum of nonzero predictors selected from ENET
penalized Cox’s model by
ERSi ¼ RPj¼1b^jEji þ RðP1Þðk¼1ÞRPl¼kþ1b^klEki Eli þ RPm¼1b^mðEmi Þ2
(1)
where Eji (j=1, . . ., p) is the log-transformed concentration of
the j-th metal in the testing set; b^j is the beta coefficient of
the j-th metal in ENET; b^kl is the beta coefficient of interaction
between metals k and l; and b^m is the coefficient of the
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squared term of the m-th metal. All beta coefficients were
estimated in the training set. Note that coefficients of less-
important predictor terms were shrunk to zero by ENET. The
sample R code for construction of the ERS using ENET is
available at https://github.com/um-mpeg/Environmental-
Risk-Score. We then investigated whether the incorporation
of the ERS in the Cox’s model with established risk factors
improved the prediction of CVD mortality.
The following metrics were then calculated to assess the
improvement of inclusion of the blood metal predictors in risk
prediction models in the testing set: (1) C-statistic, to quantify
the concordance in predicted and observed survival times
between subjects41; (2) net reclassification improvement
(NRI) with prespecified risk categories (0–5%, 5–10%, 10–
20%, and >20%); (3) continuous NRI, which does not require
discrete risk categories, to quantify the proportions of cases
correctly assigned a higher predictive probability and non-
cases correctly assigned a lower probability by inclusion of
additional predictors42; and (4) integrated discrimination
improvement (IDI), to quantify the improved sensitivity
without affecting specificity in updated prediction models.42
In a sensitivity analysis, we additionally adjusted for the
following potential confounding factors in the Cox models,
including the NHANES survey cycles, intensity of current
exposure to tobacco smoke using serum cotinine levels,23
cumulative smoking using number of pack-years,23 and
seafood intake using the total amount of omega-3 fatty acid
intake (sum of eicosapentaenoic acid and docosahexaenoic
acid) based on 24-hour dietary recall,43 which were not used
as predictors in the PCE. For comparison purpose, we also
fitted a Cox model including CRP (log-transformed), as 1 of
the most studied inflammatory biomarkers in association with
CVD,6,7,9,44 in addition to the established risk factors. This
analysis was performed in a subpopulation of the testing set
excluding the participants from NHANES 2011–2012, in
which CRP data were not available. A similar comparison was
also made by fitting a Cox model including family history of
CVD in addition to the established risk factors. All analyses
were conducted by R aoftware (version 3.4.0; www.R-project.org).
Results
Characteristics of the study population in both training and
testing sets are summarized in Table 1. In general, charac-
teristics were similar in the 2 data sets. In the training set,
participants had a mean age of 59.4 years, ranging from 40 to
85 years. During the follow-up period (median, 7.1 years;
range, 0.1–16.8), 1211 participants died; 261 deaths were
from CVD. In the testing set, mean age at baseline was
59.3 years (range, 40–85). During the follow-up (median,
7.2 years; range, 0.2–16.7), 1207 participants died, among
which 256 were from CVD. Median concentrations of blood
lead and cadmium were 1.62 lg/dL and 0.40 lg/L, respec-
tively, in both training and testing sets. Median concentration
of blood mercury was 1.00 lg/L in the training set and
0.97 lg/L in the testing set.
In ENET penalized Cox model fitted using the training data,
a total of 7 blood metal predictors were retained (after
shrinkage) as nonzero predictors of CVD death: 2 linear terms
(blood cadmium, b=0.13; blood mercury, b=0.09); 2
squared terms (blood lead, b=0.01; blood mercury,
b=0.001); and all 3 pairwise linear interactions (between
blood lead and cadmium, b=0.03; between blood lead and
mercury, b=0.01; between blood cadmium and mercury,
Table 1. Baseline Characteristics of the Study Cohort
(NHANES 1999–2012)
Characteristic
Training Set
(n=8043)
Testing Set
(n=7985)
No. (%) death of all causes 1211 (15.1) 1207 (15.1)
No. (%) death of CVD 261 (3.2) 256 (3.2)
Follow-up, median (range), y 7.1 (0.1–16.8) 7.2 (0.2–16.7)
Age, mean (SD), y 59.4 (12.9) 59.3 (12.8)
No. (%) female 4169 (51.8) 4239 (53.1)
No. (%) racial/ethnical groups
White 4072 (50.6) 3990 (50.0)
Black 1600 (19.9) 1631 (20.4)
Hispanic* 1910 (23.8) 1904 (23.8)
Other race 462 (5.7) 461 (5.8)
No. (%) current smoker 1519 (18.9) 1580 (19.8)
SBP, mean (SD), mm Hg 129 (20) 129 (20)
Total cholesterol, mean (SD),
mg/dL
202.14 (42.32) 201.52 (42.62)
HDL cholesterol, mean (SD),
mg/dL
53.71 (16.56) 53.61 (16.14)
No. (%) diabetes mellitus 1540 (19.1) 1641 (20.6)
BMI†, mean (SD), kg/m2 29.2 (6.5) 29.2 (6.4)
Blood lead, median (IQR),
lg/dL
1.62 (1.10–2.49) 1.62 (1.10–2.44)
Blood cadmium, median
(IQR), lg/L
0.40 (0.26–0.66) 0.40 (0.26–0.67)
Total blood mercury,
median (IQR), lg/L
1.00 (0.52–1.93) 0.97 (0.50–1.92)
SI conversion factor: To convert values for blood lead concentrations to lmol/L, multiply
by 0.0483; to convert values for blood cadmium concentrations to nmol/L, multiply by
8.897; to convert values for blood mercury concentrations to nmol/L, multiply by 4.99.
BMI indicates body mass index; CVD, cardiovascular disease; HDL, high-density
lipoprotein; IQR, interquartile range; NHANES, National Health and Nutrition Examination
Survey; SBP, systolic blood pressure; SI, system of units.
*Combined from Mexican American and other Hispanic in NHANES.
†
Calculated as weight in kilograms divided by the square of height in meters.
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b=0.04; Table 2). All other predictor terms were shrunk to
zero. These beta coefficients were then incorporated as the
weights into the construction of the ERS in the testing set
according to the formula (1). The ERS ranged from 0.96 to
0.35 with a mean (SD) equal to 0.11 (0.16) in the testing
set. Higher values in ERS indicate more susceptibility to CVD
death in relation to exposure to multiple metals. The
multivariable adjusted hazard ratio of CVD death comparing
the 75th to 25th percentile of ERS was 1.84 (95% CI, 1.48,
2.27; Figure).
An increase in C-statistic for the prediction of CVD
mortality was observed when predictors of blood metals were
incorporated into a model with established risk factors
(Table 3). The C-statistic estimate was highest for the addition
of the full combination of metal predictors, including all 3
linear term, 3 squared term, and 3 pairwise interactions,
improving C-statistic from 0.845 (95% CI, 0.822, 0.868) to
0.857 (95% CI, 0.835, 0.879) in the testing set. Beta
coefficients (95% CI) of the full combination of blood metal
predictors in Cox’s models are shown in Table S1. Addition of
the ERS to the model with established risk factors also
improved the C-statistic to 0.854 (95% CI, 0.831, 0.876).
Reclassification for participants who died from CVD and for
those who were alive in the testing set is summarized in
Table 4. The addition of the full combination of blood metal
predictors to the established risk factors led to a significant
improvement in risk reclassification with an NRI of 0.08 (95%
CI, 0.01, 0.14), a continuous NRI of 0.36 (95% CI, 0.24, 0.48),
and an IDI of 0.011 (95% CI, 0.006, 0.016). The addition of the
ERS in the model also significantly improved the risk
reclassification with an NRI of 0.07 (95% CI, 0.01, 0.13), a
continuous NRI of 0.27 (95% CI, 0.15, 0.40), and an IDI of
0.006 (95% CI, 0.002, 0.010; Table S2).
In a sensitivity analysis, additional adjustment for the
NHANES survey cycles, serum cotinine level, number of pack-
years of tobacco smoking, and omega-3 fatty acid intake did
Table 2. Selected Blood Metal Predictors* in Elastic-Net
Penalized Cox’s Regression† for Cardiovascular Death in the
Training Set
Selected Nonzero Blood
Metal Predictor
b for Log-Transformed
Metal Concentrations‡
Linear terms
Cadmium 0.13
Mercury 0.09
Squared terms
Lead 0.01
Mercury 0.001
Pairwise interactions
Lead9cadmium 0.03
Lead9mercury 0.01
Cadmium9mercury 0.04
*Logarithmic transformations with natural base were applied to all the blood metal
concentrations.
†
Age, sex, race/ethnicity (white vs black vs Hispanic vs other races), and current
smoking status were forced in the model during variable selection. Other established risk
factors for cardiovascular disease were not forced in model selection because of to their
potential role of intermediates on the pathways between blood metals and
cardiovascular death.
‡
Beta coefficients of selected predictors were used as weights in the following
construction of the environmental risk score.
Figure. Hazard ratios for death from cardiovascular disease,
according to individual blood metal concentrations and the
Environmental Risk Score in the testing set. Hazard ratio (95%
CI) comparing the 75th vs the 25th percentile of each variable.
Blood lead, blood cadmium, and blood mercury were log
transformed. Each variable was included separately in each
Cox’s model. All models were adjusted age, sex, race/ethnicity,
current smoking status, systolic blood pressure, use of antihy-
pertensive medications, total cholesterol level, high-density
lipoprotein cholesterol level, diabetes mellitus, and body mass
index. ERS indicates environmental risk score; HR, hazard ratio.
Table 3. C-Statistics for Cox’s Regression Models Predicting
Death From Cardiovascular Disease in the Testing Set
Risk Factors
C-Statistics for CVD
Death (95% CI)
Established risk factors* 0.845 (0.822, 0.868)
Established+blood lead (linear term) 0.849 (0.826, 0.872)
Established+blood cadmium (linear term) 0.851 (0.829, 0.874)
Established+blood mercury (linear term) 0.847 (0.824, 0.871)
Established+3 linear term+3 squared
term+3 pairwise interactions of blood
lead, cadmium, and mercury
0.857 (0.835, 0.879)
Established+ERS 0.854 (0.831, 0.876)
CVD indicates cardiovascular disease; ERS, environmental risk score.
*Established risk factors include age, sex, race/ethnicity, current smoking status,
systolic blood pressure, use of antihypertensive medications, total cholesterol level,
high-density lipoprotein cholesterol level, diabetes mellitus, and body mass index.
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not alter our findings significantly, in terms of both associ-
ations between metal predictors/ERS and CVD mortality
(Figure S2) and improvements in C-statistics (Table S3). In
addition, a sensitivity analysis was performed with the CRP
and family history of CVD included in the models, separately,
based on 6535 participants in the testing set in which the
information on CRP was available. In this subpopulation, a
similar association between ERS and CVD mortality was
observed as in the primary analysis, which was stronger than
the associations of both CRP and family history of CVD with
CVD mortality (Figure S3). In the same subpopulation, greater
improvement in risk prediction for CVD death was observed
when either ERS or the full combination of metal predictors
were added, compared with addition of CRP or family history,
in the model adjusting for the established risk factors, as
evidenced by greater increases in C-statistics (Table S4), as
well as greater NRI and IDI (data not shown).
Discussion
We examined blood markers of toxic metals, including lead,
cadmium, and mercury, for predicting the risk of CVD death
above and beyond the established CVD risk factors, in a
representative sample of US adults aged ≥40 years. The use
of multiple blood metal predictors, by either incorporating a
full combination of metal predictors including all linear terms,
squared terms, and pairwise interactions simultaneously or
adding the ERS as an integrated measure of cardiovascular
health effects of exposure to blood metal mixtures, signifi-
cantly improved risk prediction for CVD death, as evidenced
by the increase in C-statistics, as well as the significant NRI,
continuous NRI, and IDI, in a validation data set.
To the best of our knowledge, this is the first study to
investigate the improved risk prediction of CVD death by adding
the information on exposure to environmental toxicants. We
selected blood lead, blood cadmium, and total blood mercury
as representative measures of environmental cardiovascular
risk factors, on the basis of scientific evidence and data
availability. Multiple disease pathways including impaired renal
function, mitochondrial dysfunction, HDL dysfunction, sys-
temic oxidative stress, inflammation, and epigenetic and
endocrine disruption mechanisms have been suggested as
potential mechanisms underlying the association between
exposure to toxic metals and CVD risks.25,45–49 In humans, an
increased cardiovascular mortality has been attributed to
elevated blood lead concentrations in the US general popula-
tion22,50 Meta-analyses and systematic reviews have demon-
strated that there is sufficient evidence of the association of
lead exposure with hypertension.20,38 Blood cadmium has also
been shown to be an important determinant of all-cause and
CVDmortality, increased risk of peripheral arterial disease, and
elevated blood pressure.23,51,52 Mercury was suggested to
contribute to the development of CVD, though data regarding
the association between blood mercury and cardiovascular end
points were inconsistent.43,53,54 It is important to note that this
association may be confounded by seafood consumption,
which raises mercury concentrations but lowers cardiovascular
risk.55 In our study, an inverse association between blood
mercury and CVD mortality was observed, even after further
adjustment for omega-3 fatty acid intake (Figure S2). Higher
mercury exposures have also been associated with lower risks
of cardiovascular disease and hypertension in previous stud-
ies.43,53 However, to the best of our knowledge, there is no
biological evidence supporting that mercury itself would induce
cardiovascular benefits. The observed inverse association may
reflect that blood concentrations of mercury are a surrogate
measure of dietary seafood consumption and thus probably
provide independent information on to what extent each
individual consumes seafood.53 It should also be noted that the
aim of the current study is to assess the predictive performance
of blood metal predictors, rather than to investigate causes of
disease. More potential confounding factors and complex
interactions between mercury exposure and nutrients should
be considered in studies where the association between
mercury exposure and cardiovascular outcomes is the primary
goal of investigation.
Table 4. Reclassification of Participants Who Died From
Cardiovascular Causes or Who Were Alive When All Blood
Metal Predictors Were Added to the Established Risk Factors
in the Testing Set
Model With Established
Risk Factors*
Model With Established Risk Factors and All Linear,
Squared, and Pairwise Interaction Terms of Blood
Lead, Cadmium, and Mercury†
<5% Risk
5% to
10% Risk
10% to
20% Risk
≥20%
Risk
Total
No.
Participants who died from cardiovascular disease
<5% risk 55 8 0 0 63
5% to 10% risk 7 56 21 3 87
10% to 20% risk 1 13 60 12 86
≥20% risk 0 0 5 15 20
Total no. 63 77 86 30 256
Participants who did not die
<5% risk 5690 172 0 0 5862
5% to 10% risk 325 788 176 1 1290
10% to 20% risk 6 116 312 73 507
≥20% risk 0 3 29 38 70
Total no. 6021 1079 517 112 7729
*Established risk factors include age, sex, race/ethnicity, current smoking status,
systolic blood pressure, use of antihypertensive medications, total cholesterol level,
high-density lipoprotein cholesterol level, diabetes mellitus, and body mass index.
†The net reclassification improvement equals to 0.08 (95% CI, 0.01, 0.14).
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In our study, the improvement in risk prediction for either
incorporation of the full combination of metal predictors or
the ERS was stronger than that for CRP and family history of
CVD. CRP has been investigated extensively as a marker of
inflammatory response that is useful in cardiovascular risk
predictions.6,7,9,44 The strong associations of family history
with CVD risks suggests the role of genetic predisposition as
a cardiovascular risk predictor.56,57 Our finding is in line with
the rationale of using multiple biomarkers involved in multiple
disease pathways to improve the risk prediction of death from
cardiovascular causes.9
This study suggests that the assessment of blood metals
may be useful for identifying subpopulations that may benefit
most from additional blood tests. Blood tests are commonly
used for exposure assessment of environmental toxicants.
Concentrations of lead, cadmium, and mercury in whole blood
have gained wide acceptance as the most useful tool for
screening and diagnostic testing.58 Blood lead concentrations
in adults have also been closely monitored and served as a
useful public health tool over the past 3 decades in the United
States.59 Many established CVD risk factors are downstream
effects of environmental exposures and may mediate the
effect of toxic metals on CVD risk.29,38,39 This supports the
role of blood metals as a potential upstream modifiable risk
factor to prevent the development of other established risk
factors initially, rather than treating risk factors only when
they become elevated for which a restoration is difficult to
achieve.60 Adding novel predictors, including lifestyle and
environmental factors, to the conventional prediction models
is also closely tied to the concept of precision medicine, an
emerging approach for disease treatment and prevention
based on patient characteristics such as genetics and lifestyle
factors.61,62 Current CVD prevention in clinical setting is
majorly through pharmacological treatment in an attempt to
modify the elevated clinical risk factors, yet assessing
environmental exposures contributing to the elevated CVD
risks has received little attention by the medical community.
Our finding may facilitate the additional blood test for a
limited number of toxicants for better CVD risk assessment,
particularly among patients particularly classified as “low risk”
by clinically used risk models such as Framingham Risk Score
and PCE. Furthermore, the risk prediction tool incorporating
environmental toxicants may highlight the importance to
explore novel approaches for preventing cardiovascular
outcomes in a timely manner through interventions on
underlying environmental toxicants in our human bodies. A
recent prospective cohort study of middle-aged to elderly men
reported that a “prudent” dietary pattern, characterized by
high intake of fruit, vegetables, legumes, tomatoes, poultry,
and seafood, might reduce the risk of development of
coronary heart disease in relation to bone lead, suggesting
that benefits from dietary interventions on CVD could be
achieved by shifting to diets with a combination of natural
antagonists to metals’ toxicity.21,63 The toxic metal chelation
has also been proposed recently as a secondary prevention of
atherosclerotic disease by mobilizing lead and cadmium from
their chronic tissue storage compartments and facilitating
their excretion from human bodies.64–66 This is supported by
a recent large, double-blinded, placebo-controlled, random-
ized trial of patients with previous myocardial infarction, the
Trial to Assess Chelation Therapy, that a repeated edetate
disodium chelation treatment, compared with placebo, signif-
icantly reduced the risk of adverse cardiovascular outcomes,
including recurrent myocardial infarction, stroke, coronary
revascularization, hospitalization for angina, and mortal-
ity.65,67 Nevertheless, we acknowledge that feasibility and
effectiveness of these blood metals in CVD risk assessment
and prevention when incorporated into the clinical care
setting, particular in combination with established clinically
based risk models, should be addressed in more research in
the future. From the point of view of population health and
taking the principles of precision public health into account,
our findings may also encourage the implementation of a
targeted blood toxicant screening program, especially in areas
where environmental contamination is high,68 for providing
more-efficient and -effective prevention and treatment strate-
gies and potentially reducing the cost of care.62
In our study, a better prediction performance was offered
by addition of the full combination of metal predictors or the
ERS than that by the adjustment of linear terms of blood
metals individually. This is because not only linear effects of
single metals (ie, linear dose responses), but also squared
terms as well as all the combinations of pairwise interactions
(ie, nonlinear dose responses) of multiple metals were
considered. Although the highest C-statistics were observed
for the addition of the full combination of metal predictors in
our analysis, the same strategy may not be the optimal one in
some other settings. For study of environmental toxicants, the
potential predictors may include a large number of exposures
of interest, and the relationship between these exposures and
the health outcome can be complex, including nonlinear and -
additive associations. Even with just a few exposures of
interest, the combination of nonlinear and -additive associa-
tions can lead to a high-dimensional exposure-response
relationship. As illustrated in our analysis, we considered all
the linear terms, squared terms, and pairwise interactions of
metals, yielding a total of 9 predictors to be included in the
model given 3 blood metals of interests. However, if the
number of exposure goes up, this would result in a model with
65 parameters in the case of 10 exposures, 230 parameters
in the case of 20 exposures, and more generally,
2pþ pðp 1Þn2 parameters in the case of p exposures.
Thus, in the setting of a high-dimensional environmental
exposures, fitting a Cox model including all parameters as
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illustrated above is challenging and can lead to problems with
overfitting. Our ERS powered by the advanced machine
learning algorithms (ENET) has been proven satisfactory in
analyzing high-dimensional data while handling statistical
challenges, including complex correlation structures among
metals, nonlinear relationships, and confounding by copollu-
tants.28,29 Thus, our proposed ERS is not limited to blood
metals, but can be expanded to a broader range (potentially
high dimensional) of cardiovascular risk factors encompassing
other environmental toxicants, pathophysiological biomark-
ers, lifestyle and psychosocial factors, as well as their
interactions depending on investigator’s points of view and
research questions, as a broader public health tool for risk
assessment.
Our study has several limitations. First, we selected only 3
blood metals as environmental cardiovascular risk factors
because of data availability in a large sample that can allow
development and validation of ERS. Other environmental
chemicals not measured in every NHANES cycle (eg,
dioxins)69 or in the entire NHANES sample (eg, urinary
metals) might have provided additional information to better
predict CVD mortality. Second, we did not predict the risk of
incident cardiovascular events because of the cross-sectional
nature of the NHANES study design. Our findings require
confirmations in other longitudinal cohort studies where well-
defined longitudinal cardiovascular events are available. Third,
the ENET penalized Cox’s regression, as a shrinkage-based
variable selection method, provides biased effect estimates,
and CIs and test statistics are difficult to compute. Finally,
sex-specific models were not performed because of the
limited number of CVD death providing inadequate power for
sex-stratified analyses. Sex-stratified analyses would provide
more-accurate CVD risk predictions given sex differences in
the toxicity of metals.70
Conclusions
The use of multiple predictors of exposure to blood lead,
cadmium, and mercury improves risk prediction performance
for death from cardiovascular causes over the established risk
factors. Our results require confirmations in other longitudinal
cohort studies with incident events, but have important public
health implications, given the high burden of CVD morbidity
and mortality. These findings highlight a potential utility of
blood markers of toxic metals for CVD risk assessment,
prevention, and precision health.
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SUPPLEMENTAL MATERIAL 
 
 
 
 
Table S1. Beta coefficients* of linear terms, squared terms, and pairwise interactions of 
blood metals for cardiovascular disease mortality in Cox’s regression† in the testing set. 
Covariates Beta coefficient (95% CI) 
Linear term  
  Lead 0.74 (0.07, 1.41) 
  Cadmium 0.32 (-0.16, 0.80) 
  Mercury -0.41 (-0.70, -0.12) 
Squared term  
  Lead -0.09 (-0.35, 0.17) 
  Cadmium 0.05 (-0.13, 0.23) 
  Mercury 0.01 (-0.09, 0.11) 
Pairwise interaction  
  Lead*cadmium 0.21 (-0.14, 0.56) 
  Lead*mercury 0.29 (-0.03, 0.42) 
  Cadmium*mercury 0.01 (-0.18, 0.18) 
* Beta coefficient (95% confidence interval) per 1-unit increase in each covariate based on log-
transformed blood metal concentrations.  
† All linear terms, squared terms, and pairwise interactions were simultaneously included in the 
model, adjusting for age, sex, race/ethnicity, current smoking status, systolic blood pressure, use 
of antihypertensive medications, total cholesterol level, high-density lipoprotein cholesterol 
level, diabetes, and body mass index. 
 
 
Table S2. Reclassification of participants who died from cardiovascular disease or who 
were alive when the Environmental Risk Score were added to the established risk factors in 
the testing Set. 
Model with 
established 
risk factors* 
Model with established risk factors and environmental risk score† 
 <5% Risk 5-10% Risk 10-20% Risk ≥20% Risk Total No. 
Participants who died from cardiovascular disease  
<5% Risk 53 10 0 0 63 
5-10% Risk 4 63 20 0 87 
10-20% Risk 0 15 61 10 86 
≥20% Risk 0 0 5 15 20 
Total no. 57 88 86 25 256 
Participants who did not die  
<5% Risk 5711 151 0 0 5862 
5-10% Risk 244 903 143 0 1290 
10-20% Risk 0 122 326 59 507 
≥20% Risk 0 2 31 37 70 
Total no. 5955 1178 500 96 7729 
* Established risk factors include age, sex, race/ethnicity, current smoking status, systolic blood 
pressure, use of antihypertensive medications, total cholesterol level, high-density lipoprotein 
cholesterol level, diabetes, and body mass index. 
† The net reclassification improvement equals to 0.07 (95%CI: 0.01, 0.13). 
 
 
Table S3. C-statistics for Cox’s regression models predicting death from cardiovascular 
disease in the testing set adjusting for additional covariates. 
Risk Factors C-statistics for CVD death (95% CI) 
Established risk factors + additional covariates* 0.848 (0.825, 0.872) 
Established + additional covariates + blood lead 
(linear term) 
0.851 (0.828, 0.875) 
Established + additional covariates + blood 
cadmium (linear term) 
0.854 (0.832, 0.878) 
Established + additional covariates + blood 
mercury (linear term) 
0.851 (0.827, 0.875) 
Established + additional covariates + 3 linear 
term + 3 squared term + 3 pairwise interactions 
of blood lead, cadmium, and mercury 
0.856 (0.834, 0.879) 
Established + additional covariates + ERS 0.860 (0.837, 0.882) 
 
CVD, cardiovascular disease; ERS, environmental risk score. 
* Established risk factors include age, sex, race/ethnicity, current smoking status, systolic blood 
pressure, use of antihypertensive medications, total cholesterol level, high-density lipoprotein 
cholesterol level, diabetes, and body mass index. Additional covariates include NHANES survey 
cycles, serum cotinine, pack-year of cigarette smoking, and omega-3 fatty acids from dietary 
intake.  
 
 
Table S4. C-statistics for Cox’s regression models predicting death from cardiovascular 
disease in the subpopulation of testing set*. 
Risk Factors C-statistics for CVD death (95% CI) 
Established risk factors† 0.844 (0.820, 0.868) 
Established + blood lead (linear term) 0.846 (0.823, 0.870) 
Established + blood cadmium (linear term) 0.849 (0.827, 0.873) 
Established + blood mercury (linear term) 0.847 (0.823, 0.871) 
Established + 3 linear term + 3 squared term 
+ 3 pairwise interactions of blood lead, 
cadmium, and mercury 
0.856 (0.833, 0.880) 
Established + ERS 0.854 (0.830, 0.876) 
Established + CRP 0.847 (0.824, 0.871) 
Established + family history of CVD 0.845 (0.821, 0.869) 
 
CVD, cardiovascular disease; CRP, C-reactive protein; ERS, environmental risk score. 
* All models are performed in the testing set excluding the participants enrolled in NHANES 
2011-2012 cycle, in which information on CRP is not available. 
† Established risk factors include age, sex, race/ethnicity, current smoking status, systolic blood 
pressure, use of antihypertensive medications, total cholesterol level, high-density lipoprotein 
cholesterol level, diabetes, and body mass index. 
 
 
Figure S1. Schematic diagram of study methodology in NHANES 1999-2012.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CVD, cardiovascular disease; HDL, high-density lipoprotein; ERS, environmental risk score; 
ENET, elastic net. 
Adults aged 40 years or older who had blood 
lead, cadmium and mercury measured in 
NHANES 1999-2012 (n=17,284) 
 Excluded due to no linkable 
mortality data in the in the 
National Death Index (n=24) 
Participants with no missing information 
(n=16,028) 
Excluded due to missing in systolic 
blood pressure (n=752), smoking 
(n=14), total/HDL cholesterol 
(n=258), body mass index (n=322) 
Random split (1:1)  
 Training set (n=8,043) 
Selection of blood metal predictors 
associated with CVD mortality using 
ENET penalized Cox’s regression 
 Testing set (n=7,985) 
Construction of ERS based on results of 
ENET in the training set. 
 
Evaluation of the individual blood metals, 
a combination of all linear, squared, and 
pairwise interaction terns, and the ERS 
for predicting CVD death in addition to 
established risk factors based on: 
C-statistics, 
Net reclassification improvement, 
Integrated discrimination improvement 
 
 
Figure S2. Hazard ratios for death from cardiovascular disease, according to individual 
blood metal concentrations and the Environmental Risk Score in the testing Set, after 
adjusting for additional covariates. 
 
 
ERS, environmental risk score.  
* Hazard ratio (95% confidence interval) comparing the 75th vs. the 25th percentile of each 
variable. Blood lead, blood cadmium, blood mercury were log-transformed. Each variable was 
included separately in each Cox’s model. All models were adjusted age, sex, race/ethnicity, 
current smoking status, systolic blood pressure, use of antihypertensive medications, total 
cholesterol level, high-density lipoprotein cholesterol level, diabetes, and body mass index, and 
additionally adjusted NHANES survey cycles, serum cotinine, pack-year of cigarette smoking, 
and omega-3 fatty acids from dietary intake. 
 
 
Figure S3. Hazard ratios for death from cardiovascular disease, according to individual 
blood metal concentration, the Environmental Risk Score, C-reactive protein and family 
history of cardiovascular disease in the subpopulation of testing set. 
 
 
CRP, C-reactive protein; ERS, environmental risk score; CVD, cardiovascular disease. 
* Hazard ratio (95% confidence interval) comparing the 75th vs. the 25th percentile of each 
variable, except for family history of CVD (comparing participants with family history of CVD 
with those without family history). Blood lead, blood cadmium, blood mercury were log-
transformed. Each covariates was included separately in each Cox’s model. All models were 
adjusted age, sex, race/ethnicity, current smoking status, systolic blood pressure, use of 
antihypertensive medications, total cholesterol level, high-density lipoprotein cholesterol level, 
diabetes, and body mass index. All models are performed in the testing set excluding the 
participants enrolled in NHANES 2011-2012 cycle, in which information on CRP is not 
available. 
 
